Inpharmatica experiences personnel changes

FRAMINGHAM (11/24/2003) - Inpharmatica Ltd. has seen a few personnel changes recently. Edwin Moses, a nonexecutive director of the company since July 2001, has been appointed nonexecutive chairman. Sir Harry Solomon, the company's former chairman, remains as a board director. Former British Biotech Pharmaceuticals Ltd. director of research Andrew Ayscough joins as director of chemistry. And a team of seven medicinal chemists was recently recruited from Millennium Pharmaceuticals Inc. in Cambridge, England, following that company's decision to close its Cambridge site.

Join the newsletter!

Or

Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.

Membership is free, and your security and privacy remain protected. View our privacy policy before signing up.

Error: Please check your email address.

More about British BiotechMillennium PharmaceuticalsSIRSolomon

Show Comments
[]